Koppikar Utpal has filed a Form 3 with the SEC, indicating a change in his ownership status related to Insmed Inc. This filing is significant as it reflects ongoing developments within the company and the broader pharmaceutical preparations sector.
Koppikar Utpal is a director at Insmed Inc, a company based in Bridgewater, New Jersey. Insmed operates within the pharmaceutical preparations industry, focusing on innovative treatments. The company's recent filings include a Form 4 submitted on the same day, October 20, 2026, which may provide further insights into ownership changes.
The Form 3 filing states that Koppikar Utpal is now reported as a director, which may influence the company’s governance and strategic direction. The filing specifies that Koppikar has a limited power of attorney for SEC reporting purposes, allowing him to delegate certain responsibilities related to filing requirements.
This update may affect various stakeholders, including shareholders and regulatory bodies, who monitor ownership changes and their implications for corporate governance. Koppikar's involvement in Insmed could indicate potential shifts in the company's strategy or operations.
The filing does not specify what happens next, leaving open questions about future developments related to Koppikar's role and any potential strategic changes at Insmed.
Ownership Details
The Form 3 filing indicates that Koppikar Utpal currently owns one security of Insmed Inc, which is classified under the Central Index Key (CIK) 0001104506. This ownership reflects his position and involvement in the company, further emphasizing his role in corporate governance.
Power of Attorney
Notably, the filing includes a Limited Power of Attorney that Koppikar has granted to Michael A. Smith, Katrina S. Atieh, and Ian S. Macdonald. This delegation allows them to act on his behalf for SEC reporting purposes, including the execution and filing of Forms 3, 4, and 5, as well as Forms 144 related to the company's securities. The Power of Attorney is designed to facilitate compliance with the reporting requirements under the Securities Exchange Act of 1934.
Company Background
Insmed Inc, incorporated in Virginia, operates in the pharmaceutical preparations sector, specifically categorized under the Standard Industrial Classification (SIC) code 2834. The company is headquartered at 700 US Highway 202/206 in Bridgewater, New Jersey, and has a fiscal year that ends on December 31.
The filing does not provide any information regarding Koppikar's specific plans or intentions for his role within Insmed, nor does it detail any potential strategic initiatives he may advocate for as a director.